DYANAVEL XR

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 24478-110
  • Package NDC 24478-110-01
  • Application number NDA210526
  • SPL ID 32c90701-fe4a-4d5a-b3bb-e9ccf0416ece
  • SPL set ID ae304b29-0b40-40ec-ad0d-76b742d4a9b9
  • UNII CK833KGX7E
  • RxCUI 1720586
  • RxCUI 1720592
  • RxCUI 2585460
  • RxCUI 2585461
  • RxCUI 2585462
  • RxCUI 2585465
  • RxCUI 2585468
  • RxCUI 2585471
  • RxCUI 2585473
  • RxCUI 2585476

What the source publishes

Labeler
NextWave Pharmaceuticals, Inc
Active ingredients
amphetamine
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:24478-110_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece
{
  "name": "DYANAVEL XR",
  "splId": "32c90701-fe4a-4d5a-b3bb-e9ccf0416ece",
  "labels": [
    {
      "setId": "ae304b29-0b40-40ec-ad0d-76b742d4a9b9",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae304b29-0b40-40ec-ad0d-76b742d4a9b9",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae304b29-0b40-40ec-ad0d-76b742d4a9b9"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "NextWave Pharmaceuticals, Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-110-01)",
      "package_ndc": "24478-110-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220801"
    }
  ],
  "productId": "24478-110_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "24478-110",
  "deaSchedule": "CII",
  "genericName": "amphetamine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "AMPHETAMINE",
      "strength": "20 mg/1"
    }
  ],
  "applicationNumber": "NDA210526",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20211104",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175739",
      "N0000175729"
    ],
    "upc": [
      "0324478102029",
      "0324478108014",
      "0324478110017",
      "0324478109011"
    ],
    "unii": [
      "CK833KGX7E"
    ],
    "rxcui": [
      "1720586",
      "1720592",
      "2585460",
      "2585461",
      "2585462",
      "2585465",
      "2585468",
      "2585471",
      "2585473",
      "2585476"
    ],
    "spl_set_id": [
      "ae304b29-0b40-40ec-ad0d-76b742d4a9b9"
    ],
    "pharm_class_pe": [
      "Central Nervous System Stimulation [PE]"
    ],
    "pharm_class_epc": [
      "Central Nervous System Stimulant [EPC]"
    ],
    "manufacturer_name": [
      "NextWave Pharmaceuticals, Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:24478-110_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece"